Effect of BZG-4000, a novel multi-targeted kinase inhibitor with potent anticancer activity, on a hepatocellular carcinoma xenograft model

por Qiu, Yun-Qing, Zhou, Jue, Kang, Xin-Shan, Ding, Lie-Ming, Yu, Wei, Tan, Fen-Lai, Deng, Dan-Feng
Publicado 2014

Adjuvant icotinib versus observation in patients with completely resected EGFR-mutated stage IB NSCLC (GASTO1003, CORIN): a randomised, open-label, phase 2 trial

por Ou, Wei, Li, Ning, Wang, Bao-Xiao, Zhu, Teng-Fei, Shen, Zhi-Lin, Wang, Tao, Chang, Wu-Guang, Chang, Zeng-Hao, Hu, Xin-Xin, Pu, Yue, Ding, Lie-Ming, Wang, Si-Yu
Publicado 2023